Login to Your Account

Chiron's Pulminiq 'Approvable,' But Flu Vaccine Trouble Arises

By Karen Pihl-Carey

Monday, July 18, 2005
After to a split advisory committee vote last month on Chiron Corp.'s Pulminiq, the FDA issued an approvable letter but asked for another study to confirm efficacy of the lung transplant drug. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription